drugset
drugset / Trial / NCT02003547

A Single Centre Study to Evaluate 3 Ophthalmic Formulations in Healthy Subjects

NCT02003547 ↗

Phase 1 Completed 21 enrolled Amakem, NV
RandomizedCrossoverQuadruple-blindTreatment

Summary

A Single Centre, Placebo-Controlled, Double-Masked, Sequential Designed Study to Evaluate 3 Ophthalmic Formulations of AMA0076 in Healthy Subjects

Timeline

Start
2013-09
Primary completion
2013-12
Completion
2013-12

Drugs

EvaluationDrugModalityDoseRoute
Subject AMA0076 Unknown — Topical

Indications

glaucoma ocular hypertension